Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cell biology, Chemistry, Biology, Cystic fibrosis transmembrane conductance regulator, Chloride channel, and Cystic fibrosis.
Anoctamin 9 determines Ca2+ signals during activation of T-lymphocytes
Dystonia caused by ANO3 variants is due to attenuated Ca2+ influx by ORAI1
Case Report of Pediatric HPCA-Associated Dystonia: Analysis of Ca2+ and K+ Channel Dynamics and Experience With Pallidal Deep Brain Stimulation
Inhibition of mucus secretion by niclosamide and benzbromarone in airways and intestine
Anoctamins in epithelial transport
A novel SLC26A9 inhibitor, S9-A13, reveals a minor contribution of SLC26A9 to constitutive airway chloride secretion
Functional Interdependence of Anoctamins May Influence Conclusions from Overexpression Studies
Niclosamide, but not ivermectin, inhibits anoctamin 1 and 6 and attenuates inflammation of the respiratory tract
The Anion Channel TMEM16a/Ano1 Modulates CFTR Activity, but Does Not Function as an Apical Anion Channel in Colonic Epithelium from Cystic Fibrosis Patients and Healthy Individuals
Broadening the clinical spectrum: molecular mechanisms and new phenotypes of <i>ANO3</i>-dystonia
SLC26A9 in airways and intestine: secretion or absorption?
TMEM16A/F support exocytosis but do not inhibit Notch-mediated goblet cell metaplasia of BCi-NS1.1 human airway epithelium
KCNE1 does not shift TMEM16A from a Ca2+ dependent to a voltage dependent Cl- channel and is not expressed in renal proximal tubule
Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins
Pathogenic Relationships in Cystic Fibrosis: CFTR, SLC26A9 and Anoctamins
Airway Delivery of Hydrogel-Encapsulated Niclosamide for the Treatment of Inflammatory Airway Disease
The <scp>SLC26A9</scp> inhibitor <scp>S9‐A13</scp> provides no evidence for a role of <scp>SLC26A9</scp> in airway chloride secretion but suggests a contribution to regulation of <scp>ASL pH</scp> and gastric proton secretion
Pharmacological inhibitors of the cystic fibrosis transmembrane conductance regulator exert off-target effects on epithelial cation channels
Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
Expression of SLC26A9 in Airways and Its Potential Role in Asthma
A <scp>TMEM16J</scp> variant leads to dysregulated cytosolic calcium which may lead to renal disease
Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic Fibrosis
Paneth Cell Secretion in vivo Requires Expression of Tmem16a and Tmem16f
P. aeruginosa Induced Lipid Peroxidation Causes Ferroptotic Cell Death in Airways
CLCA1 Regulates Airway Mucus Production and Ion Secretion Through TMEM16A
The molecular mechanism of CFTR‐ and secretin‐dependent renal bicarbonate excretion
Mucus Release and Airway Constriction by TMEM16A May Worsen Pathology in Inflammatory Lung Disease
Gender-Dependent Phenotype in Polycystic Kidney Disease Is Determined by Differential Intracellular Ca2+ Signals
IRAG2 Interacts with IP3-Receptor Types 1, 2, and 3 and Regulates Intracellular Ca2+ in Murine Pancreatic Acinar Cells